With NanoFusion, Geyser Addresses Challenge to Extract-Based Producers
July 8th, 2019
App, Exclusive, News, Top News
While cannabis-infused products are the fastest-growing and most lucrative segment of the industry, a key challenge in producing cannabinoids for ingestion or absorption through the skin is their insolubility. Due to their oily composition they are naturally hydrophobic, meaning that their molecules are water-repellant, making it harder for the body to absorb them. The result is inconsistent, unreliable dosing and onset times of up to three hours.
Geyser Brands Inc. (TSXV: GYSR), a Health Canada-approved Licensed Producer based in Vancouver, BC, has found a solution to this problem with its ground-breaking developments in nanotechnology, dubbed NanoFusion, which breaks down cannabinoid particles and combines them with naturally-occurring surfactants which lower the surface tension between cannabinoids and water, resulting in a compound that is water compatible.
Researched and developed by Geyser’s Senior R&D chemist with over 35 years of experience in state-of-the-art facilities and produced using natural, biocompatible, biodegradable, non-toxic and non-inflammatory materials, NanoFusion is a tasteless, scentless, all-natural nano-particle delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
All of the products in Geyser’s diverse portfolio are produced using NanoFusion, making them more reliable and consistent, requiring smaller doses to deliver desired health & wellness results, increasing bioavailability and skin permeation, and greatly reducing the speed of onset. NanoFusion also improves the transport of active ingredients for site-specific targeting by delivering active ingredients across cell membranes for release within the cell, and release times can be adjusted based on the delivery method. It also increases the stability of molecules, giving the company’s products a longer shelf-life than those produced using traditional methods.
Andreas Thatcher, CEO of Geyser Brands Inc, said, “We created it in response to varying and diverse consumer preferences and needs, making sure it had an all-natural composition free of any toxic additives, solvents, or fillers – which addressed the harsh bitter aftertaste and/or oily texture many of the products in the market have. At the same time, we ensured that consumers could do more with less by designing it for long, stable shelf life and increasing its bioavailability, meaning that they need lower dose per use, and making us their go-to for reliable, high quality products.”
Potential Solace Acquisition Expands Offering, Licensing Enables Production
Geyser recently entered into a definitive agreement to acquire Solace Management Group and its assortment of brands ranging from the medical and adult recreational cannabis markets to pet health & wellness, including Apothecary Naturals, a line of 100% natural hemp-based topical, cosmetics, and self-care products, and Apawthecary Pets, Canada’s leading hemp-infused pet brand, with products in over 400 pet stores and 100 veterinary clinics.
On June 18th, the company announced that its wholly owned Licensed Producer, 0957102 B.C. Ltd. dba Apothecary Botanicals, has successfully received a coveted Standard Processing License from Health Canada, allowing it to extend its brands into the highly regulated Canadian cannabis market, with production expected to commence in the next 90 days, and add manufacturing capacity for edibles, extracts, and topicals.
In anticipation, Apothecary Botanicals began modifications to its Port Coquitlam, B.C. facility, expected to be completed by the end of the month. The modifications and processes are designed to deliver GMP-compliant capacity, and with the installation of manufacturing equipment and the completion of distribution agreements, Apothecary Botanicals will be able to service the production needs of Geyser’s existing and third-party brands.
Armed with a diverse array of established brands powered by its proprietary NanoFusion technology, which solves the biggest challenge to its product offering, Geyser is a company on the rise. Investors unfamiliar with Geyser may just want to take a closer look.
For more information, keep watching this page, or visit https://www.geyserbrands.com/
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.